Zoetis Inc.

ZTS · NYSE

Zoetis reported FY2025 revenue of $9.47 billion and Q1 2026 revenue of $2.26 billion, with the official record tying the thesis to companion-animal demand, livestock cycles, product innovation, inventory quality, debt and cash conversion.

Follow Add to Watchlist Ask Question

NYSE ZTS Coverage Bootstrap Zoetis Inc.

Latest ReportMay 19, 2026Zoetis: the animal-health compounder has to prove growth after inventory and livestock cyclesView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Company filters1 of 1 reports match

Clear filters

Add tags

Selected tags

NYSE

Clear tags

Latest Thesis

Zoetis: the animal-health compounder has to prove growth after inventory and livestock cycles

May 19, 2026Research reportSlides available

Read report Open slides Discussion (0)

Zoetis Inc.the animal-health compounder has to prove growth after inventoryMay 19, 2026

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Recent Reports

Compact report index for this company.

View all 1 reports ->

ReportTypeUpdatedReadActions

Zoetis: the animal-health compounder has to prove growth after inventory and livestock cyclesZoetis reported FY2025 revenue of $9.47 billion and Q1 2026 revenue of $2.26 billion, with the official record tying the thesis to companion-animal demand, livestock cycles, product innovation, inventory quality, debt and cash conversion.NYSEMay 19, 2026Research reportRead Slides